Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

EC Approves BMS and AstraZeneca’s Type 2 Diabetes Therapy for Renally Impaired Patients

Onglyza 2.5 mg can now be used to treat individuals with moderate-to-severe renal impairment.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »